Brief report: Chikungunya viral arthritis in the United States: A mimic of seronegative rheumatoid arthritis

Arthritis and Rheumatology

Volumn 67, Issue 5, 2015, Pages 1214-1220

  Miner, Jonathan J ^a   Yeang, Han Xian Aw ^a   Fox, Julie M ^a   Taffner, Samantha ^a   Malkova, Olga N ^a   Oh, Stephen T ^a   Kim, Alfred H J ^a   Diamond, Michael S ^a   Lenschow, Deborah J ^a   Yokoyama, Wayne M ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IBUPROFEN; NAPROXEN; PREDNISONE; ANTINUCLEAR ANTIBODY; CYCLIC CITRULLINATED PEPTIDE; CYCLOPEPTIDE; RHEUMATOID FACTOR;

ADULT; ARTHRALGIA; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CHIKUNGUNYA; CHIKUNGUNYA VIRAL ARTHRITIS; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOMETRY; DESQUAMATION; DIFFUSE ARTHRITIS; DRUG WITHDRAWAL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FEVER; GASTROINTESTINAL SYMPTOM; GENERAL CONDITION DETERIORATION; HAITI; HEADACHE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; JOINT STIFFNESS; JOINT SWELLING; MACULOPAPULAR RASH; MALE; MORNING STIFFNESS; NECK PAIN; PERIPHERAL BLOOD MONONUCLEAR CELL; PERSISTENT SYMMETRIC POLYARTHRITIS; POLYARTHRITIS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; UNITED STATES; ADOLESCENT; ARTHRITIS, INFECTIOUS; ARTHRITIS, RHEUMATOID; CASE CONTROL STUDY; CHIKUNGUNYA FEVER; CHIKUNGUNYA VIRUS; DIFFERENTIAL DIAGNOSIS; IMMUNOLOGY; MIDDLE AGED; TRAVEL; YOUNG ADULT;

ADOLESCENT; ADULT; ANTIBODIES, ANTINUCLEAR; ARTHRITIS, INFECTIOUS; ARTHRITIS, RHEUMATOID; CASE-CONTROL STUDIES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CHIKUNGUNYA FEVER; CHIKUNGUNYA VIRUS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HAITI; HUMANS; MALE; MIDDLE AGED; PEPTIDES, CYCLIC; RHEUMATOID FACTOR; TRAVEL; UNITED STATES; YOUNG ADULT;

EID: 84928610105     PISSN: 23265191     EISSN: 23265205     Source Type: Journal    
DOI: 10.1002/art.39027     Document Type: Article

References (15)

1. Ross R,. The Newala epidemic. J Hyg (Lond) 1956; 54: 177-91.
2. Kariuki Njenga M, Nderitu L, Ledermann JP, Ndirangu A, Logue CH, Kelly CH, et al. Tracking epidemic chikungunya virus into the Indian Ocean from East Africa. J Gen Virol 2008; 89: 2754-60.
3. Staples JE, Breiman RF, Powers AM., Chikungunya fever: an epidemiological review of a re-emerging infectious disease. Clin Infect Dis 2009; 49: 942-8.
4. Enserink M., Crippling virus set to conquer western hemisphere. Science 2014; 344: 678-9.
5. Kuehn BM., Chikungunya virus transmission found in the United States: US health authorities brace for wider spread. JAMA 2014; 312: 776-7.
6. Tsetsarkin KA, Vanlandingham DL, McGee CE, Higgs S., A single mutation in chikungunya virus affects vector specificity and epidemic potential. PLoS Pathog 2007; 3: e201.
7. Gubler DJ., The continuing spread of West Nile virus in the western hemisphere. Clin Infect Dis 2007; 45: 1039-46.
8. Schilte C, Staikovsky F, Couderc T, Madec Y, Carpentier F, Kassab S, et al. Chikungunya virus-associated long-term arthralgia: a 36-month prospective longitudinal study. PLoS Negl Trop Dis 2013; 7: e2137.
9. Hoarau J-J, Jaffar Bandjee M-C, Krejbich Trotot P, Das T, Li-Pat-Yuen G, Dassa B, et al. Persistent chronic inflammation and infection by chikungunya arthritogenic alphavirus in spite of a robust host immune response. J Immunol 2010; 184: 5914-27.
10. Manimunda SP, Vijayachari P, Uppoor R, Sugunan AP, Singh SS, Rai SK, et al. Clinical progression of chikungunya fever during acute and chronic arthritic stages and the changes in joint morphology as revealed by imaging. Trans R Soc Trop Med Hyg 2010; 104: 392-9.
11. Fischer M, Staples JE., Notes from the field: chikungunya virus spreads in the Americas-Caribbean and South America, 2013-2014. MMWR Morb Mortal Wkly Rep 2014 6;63: 500-1.
12. Pal P, Dowd KA, Brien JD, Edeling MA, Gorlatov S, Johnson S, et al. Development of a highly protective combination monoclonal antibody therapy against chikungunya virus. PLoS Pathog 2013; 9: e1003312.
13. Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO III, et al. 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 2010; 62: 2569-81.
14. Chopra A, Saluja M, Venugopalan A., Effectiveness of chloroquine and inflammatory cytokine response in patients with early persistent musculoskeletal pain and arthritis following chikungunya virus infection. Arthritis Rheumatol 2014; 66: 319-26.
15. Labadie K, Larcher T, Joubert C, Mannioui A, Delache B, Brochard P, et al. Chikungunya disease in nonhuman primates involves long-term viral persistence in macrophages. J Clin Invest 2010; 120: 894-906.